Search

Search Constraints

You searched for: Author/Creator Nagashima, Seiji

Search Results

1. Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial. (16th January 2019)

2. Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study. Issue 16 (8th July 2022)

3. Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Issue 1 (24th November 2016)

4. Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer. Issue 9 (16th July 2019)

5. Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study. Issue 2 (18th December 2019)

6. Phase II trial of a non‐platinum triplet for patients with advanced non‐small cell lung carcinoma (NSCLC) overexpressing ERCC1 messenger RNA. Issue 3 (9th January 2019)

7. Protein induced by vitamin K absence or antagonist II (PIVKA‐II) producing large cell neuroendocrine carcinoma (LCNEC) of lung with multiple liver metastases: A case report. Issue 2 (11th January 2017)